| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Pr8/22 |
|---|
| Description | The cell line Pr8/22 has been derived from P388, a methylcholanthrene-induced lymphoid neoplasm originating in DBA/2 mouse and converted to ascitic form in the first mouse transfer. Pr8/22 is resistant to daunorubicin and is multi drug resistant (MDR). Cells should be treated with the drug at least once a month and before freezing, however after resuscitating daunorubicin should not be added until the first passage. It is advisable to keep a backup culture which is not drug-challenged. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | CSC-C9518J |
|---|
| Price | |
|---|
| Order / More Info | Pr8/22 from CREATIVE BIOARRAY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|